Bank of America Securities Keeps Their Buy Rating on Icon (ICLR)
Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Icon (ICLR – Research Report) today and set a price target of ...
Buy Rating on Icon: Navigating Short-term Challenges with Strong Competitive Position and Strategic Initiatives
Michael Ryskin, an analyst from Bank of America Securities, maintained the Buy rating on Icon (ICLR – Research Report). The associated price ...
TMCnet8h
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth quarter and full year 2024 ...
TD Cowen cuts ICON stock price target to $254, maintains Buy rating
TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.
ICON Public (NASDAQ:ICLR) Receives Outperform Rating from William Blair
ICON Public (NASDAQ:ICLR – Get Free Report)‘s stock had its “outperform” rating reissued by William Blair in a research note ...